BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28541139)

  • 1. Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology.
    Hoss U; Budiman ES
    Diabetes Technol Ther; 2017 May; 19(S2):S44-S50. PubMed ID: 28541139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study.
    Hoss U; Jeddi I; Schulz M; Budiman E; Bhogal C; McGarraugh G
    Diabetes Technol Ther; 2010 Aug; 12(8):591-7. PubMed ID: 20615099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor Age.
    Tsoukas M; Rutkowski J; El-Fathi A; Yale JF; Bernier-Twardy S; Bossy A; Pytka E; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):203-207. PubMed ID: 31613140
    [No Abstract]   [Full Text] [Related]  

  • 4. Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear.
    Forlenza GP; Kushner T; Messer LH; Wadwa RP; Sankaranarayanan S
    Diabetes Technol Ther; 2019 Apr; 21(4):222-229. PubMed ID: 30817171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Factory Calibration for Subcutaneous Glucose Sensors in Subjects With Diabetes.
    Hoss U; Budiman ES; Liu H; Christiansen MP
    J Diabetes Sci Technol; 2014 Jan; 8(1):89-94. PubMed ID: 24876543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System.
    Bailey T; Bode BW; Christiansen MP; Klaff LJ; Alva S
    Diabetes Technol Ther; 2015 Nov; 17(11):787-94. PubMed ID: 26171659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous glucose sensing: future technology developments.
    Brauker J
    Diabetes Technol Ther; 2009 Jun; 11 Suppl 1():S25-36. PubMed ID: 19469675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an Error Model for a Factory-Calibrated Continuous Glucose Monitoring Sensor with 10-Day Lifetime.
    Vettoretti M; Battocchio C; Sparacino G; Facchinetti A
    Sensors (Basel); 2019 Dec; 19(23):. PubMed ID: 31816886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator.
    Shah VN; Laffel LM; Wadwa RP; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):428-433. PubMed ID: 29923775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring: an overview of today's technologies and their clinical applications.
    Heinemann L; Koschinsky T
    Int J Clin Pract Suppl; 2002 Jul; (129):75-9. PubMed ID: 12166611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring in the subcutaneous tissue over a 14-day sensor wear period.
    Hoss U; Budiman ES; Liu H; Christiansen MP
    J Diabetes Sci Technol; 2013 Sep; 7(5):1210-9. PubMed ID: 24124948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model of glucose sensor error components: identification and assessment for new Dexcom G4 generation devices.
    Facchinetti A; Del Favero S; Sparacino G; Cobelli C
    Med Biol Eng Comput; 2015 Dec; 53(12):1259-69. PubMed ID: 25416850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of the FlashStyle Libre system in glycemic control in children with type 1 diabetes during summer camp.
    Deja G; Kłeczek M; Chumięcki M; Strzała-Kłeczek A; Deja R; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):11-19. PubMed ID: 30083658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Home Study on Nocturnal Hypoglycemic Alarms Using a New Fully Implantable Continuous Glucose Monitoring System in Type 1 Diabetes.
    Wang X; Ioacara S; DeHennis A
    Diabetes Technol Ther; 2015 Nov; 17(11):780-6. PubMed ID: 26177299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices.
    Garg SK; Akturk HK
    Diabetes Technol Ther; 2018 Jun; 20(6):391-394. PubMed ID: 29901411
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous glucose monitoring with glucose sensors: calibration and assessment criteria.
    Lodwig V; Heinemann L;
    Diabetes Technol Ther; 2003; 5(4):572-86. PubMed ID: 14511412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Blood Glucose Measurements to Calibrate Subcutaneous Glucose Sensors: A Bayesian Multiday Framework.
    Acciaroli G; Vettoretti M; Facchinetti A; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2018 Mar; 65(3):587-595. PubMed ID: 28541194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes.
    Bonora B; Maran A; Ciciliot S; Avogaro A; Fadini GP
    J Endocrinol Invest; 2016 Dec; 39(12):1391-1399. PubMed ID: 27287421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences Between Flash Glucose Monitor and Fingerprick Measurements.
    Staal OM; Hansen HMU; Christiansen SC; Fougner AL; Carlsen SM; Stavdahl Ø
    Biosensors (Basel); 2018 Oct; 8(4):. PubMed ID: 30336581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients. Part 2. Superiority of the one-point calibration method.
    Choleau C; Klein JC; Reach G; Aussedat B; Demaria-Pesce V; Wilson GS; Gifford R; Ward WK
    Biosens Bioelectron; 2002 Aug; 17(8):647-54. PubMed ID: 12052350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.